BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38238776)

  • 21. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study.
    Lord AC; Corr A; Chandramohan A; Hodges N; Pring E; Airo-Farulla C; Moran B; Jenkins JT; Di Fabio F; Brown G
    Lancet Oncol; 2022 Jun; 23(6):793-801. PubMed ID: 35512720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection.
    Park JK; Kim YW; Hur H; Kim NK; Min BS; Sohn SK; Choi YD; Kim YT; Ahn JB; Roh JK; Keum KC; Seong JS
    Langenbecks Arch Surg; 2009 Jan; 394(1):71-7. PubMed ID: 18663464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.
    Tsujinaka S; Kawamura YJ; Konishi F; Aihara H; Maeda T; Mizokami K
    Int J Colorectal Dis; 2008 Jan; 23(1):67-76. PubMed ID: 17704925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local excision and postoperative radiotherapy for distal rectal cancer.
    Benson R; Wong CS; Cummings BJ; Brierley J; Catton P; Ringash J; Abdolell M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1309-16. PubMed ID: 11483343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer.
    Kanemitsu Y; Hirai T; Komori K; Kato T
    Dis Colon Rectum; 2010 May; 53(5):779-89. PubMed ID: 20389212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL; Chu KW
    Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.
    van Lingen CP; Zeebregts CJ; Gerritsen JJ; Mulder HJ; Mastboom WJ; Klaase JM
    Int J Gastrointest Cancer; 2003; 34(2-3):129-34. PubMed ID: 15361646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases.
    Kroon HM; Dudi-Venkata NN; Bedrikovetski S; Liu J; Haanappel A; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Sammour T
    Ann Surg Oncol; 2022 Feb; 29(2):1194-1203. PubMed ID: 34490529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
    Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
    Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
    van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ;
    Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer.
    Suzuki K; Gunderson LL; Devine RM; Weaver AL; Dozois RR; Ilstrup DM; Martenson JA; O'Connell MJ
    Cancer; 1995 Feb; 75(4):939-52. PubMed ID: 7531113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locally advanced rectal cancer: a multivariate analysis of outcome risk factors.
    Bufalari A; Boselli C; Giustozzi G; Moggi L
    J Surg Oncol; 2000 May; 74(1):2-10. PubMed ID: 10861600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence?
    Hall NR; Finan PJ; al-Jaberi T; Tsang CS; Brown SR; Dixon MF; Quirke P
    Dis Colon Rectum; 1998 Aug; 41(8):979-83. PubMed ID: 9715152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necessity of external iliac lymph nodes and inguinal nodes radiation in rectal cancer with anal canal involvement.
    Zheng R; Zhang Y; Chen R; Guan B; Lin Y; Wang B; Li X; Chi P; Chen X; Xu B
    BMC Cancer; 2022 Jun; 22(1):657. PubMed ID: 35701738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement.
    Song M; Wang H; Wang L; Li S; Zhang Y; Geng J; Zhu X; Li Y; Cai Y; Wang W
    BMC Cancer; 2022 Nov; 22(1):1196. PubMed ID: 36403007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
    Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
    World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
    Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
    World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.